Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative ICS/LAMA/LABA Inhaler Therapy in Lung Cancer Patients with COPD
jRCT1031240636Recruiting
- Sponsor
- Chiba University Hospital
- Start
- Mar 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial in chronic obstructive pulmonary disease (COPD) and bronchial carcinoma, sponsored by Chiba University Hospital. Primary endpoint: Change in trough FEV1 from baseline at 12–24 weeks postoperatively. Started Mar 2025; status: recruiting.
02
Conditions
chronic obstructive pulmonary disease (COPD)bronchial carcinoma
Beyond the preview
Go deeper on jRCT1031240636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240636.